Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J. Clin. 71, 209–249.

PubMed  Google Scholar 

Oba K., Paoletti X., Alberts S., Bang Y.J., Benedetti J., Bleiberg H., Catalano P., Lordick F., Michiels S., Morita S., Ohashi Y., Pignon J.P., Rougier P., Sasako M., Sakamoto J., Sargent D., Shitara K., Van Cutsem E., Buyse M., Byrzykowski T., GASTRIC Group 2013. Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: A meta-analysis. J. Natl. Cancer Inst. 105, 1600–1607.

Dicken B.J., Bigam D.L., Cass C., Mackey J.R., Joy A.A., Hamilton S.M. 2005. Gastric adenocarcinoma: Review and considerations for future directions. Ann. Surg. 241, 27–39.

Article  PubMed  PubMed Central  Google Scholar 

Kaprin A.D., Starinsky V.V., Shakhzadova A.O. 2020. Zlokachestvennye novoobrazovaniya v Rossii v 2019 godu. (Malignant Neoplasms in Russia in 2019). Moscow: MNIOI im. P.A. Gertsena—Filial NMITs Radiologii Minzdrava Rossii.

Lauren P. 1965. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbial. Scand. 64, 31–49.

Article  CAS  Google Scholar 

Tan P., Yeoh K.G. 2015. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 149, 1153–1162.

Article  CAS  PubMed  Google Scholar 

Bonequi P., Meneses-González F., Correa P., Rabkin C.S., Camargo M.C. 2013. Risk factors for gastric cancer in Latin-America: a meta-analysis. Cancer Causes Control. 24, 217‒231.

Article  PubMed  Google Scholar 

Strumylaite L., Zickute J., Dudzevicius J., Dregval L. 2006. Salt-preserved foods and risk of gastric cancer. Medicina (Kaunas), 42, 164–170.

PubMed  Google Scholar 

González C.A., Pera G., Agudo A., Palli D., Krogh V., Vineis P., Tumino R., Panico S., Berglund G., Simán H., Nyrén O., Agren A., Martinez C., Dorronsoro M., Barricarte A., Tormo M.J., Quiros J.R., Allen N., Bingham S., Day N., Miller A., Nagel G., Boeing H., Overland K., Tjonneland A., Bueno-De-Mesquita H.B., Boshuizen H.C., Peeters P., Numans M., Clavel-Chapelon F., Helen I., Agapitos E., Lund E., Fahey M., Saracci R., Kaaks R., Riboli E. 2003. Smoking and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int. J. Cancer. 107, 629–634.

Article  PubMed  Google Scholar 

Plummer M., Franceschi S., Vignat J., Forman D., De Martel C. 2015. Global burden of gastric cancer attributable to Helicobacter pylori. Int. J. Cancer. 136, 487–490.

Article  CAS  PubMed  Google Scholar 

Uozaki H., Fukayama M. 2008. Epstein–Barr virus and gastric carcinoma—viral carcinogenesis through epigenetic mechanisms. Int. J. Clin. Exp. Pathol. 1, 198‒216.

CAS  PubMed  PubMed Central  Google Scholar 

Bae J.M., Kim E.H. 2016. Epstein–Barr Virus and gastric cancer risk: A meta-analysis with meta-regression of case-control studies. J. Prev. Med. Public Health. 49, 97‒107.

Article  PubMed  PubMed Central  Google Scholar 

Assumpção P., Araújo T., Khayat A., Santos S., Barra W., Ishak G., Santos S., Barra W., Felipe Acioli J., Rossi B. Assumpção P. 2020. Hereditary gastric cancer: three rules to reduce missed diagnoses. World J. Gastroenterol. 26, 1382‒1393.

Article  PubMed  PubMed Central  Google Scholar 

The Cancer Genome Atlas Research Network 2014. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 513, 202–209.

Article  Google Scholar 

Matsusaka K., Kaneda A., Nagae G., Ushiku T., Kikuchi Y., Hino R., Uozaki H., Seto Y., Takada K., Aburatani H., Fukayama M. 2011. Classification of Epstein–Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 71, 7187–7197.

Article  CAS  PubMed  Google Scholar 

Zhao J., Liang Q., Cheung K.F., Kang W., Lung R.W.M., Tong J.H.M., To K.F., Sung J.J.Y., Yu J. 2013. Genome-wide identification of Epstein–Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells. Cancer. 119, 304–312.

Article  CAS  PubMed  Google Scholar 

Kandoth C., McLellan M.D., Vandin F., Ye K., Niu B., Lu C., Xie M., Zhang Q., McMichael J.F., Wyczalkowski M.A., Leiserson M.D.M., Miller C.A., Welch J.S., Walter M.J., Wendl M.C., Ley T.J., Wilson R.K., Raphael B.J., Ding L. 2013. Mutational landscape and significance across 12 major cancer types. Nature. 502, 333–339.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Astolfi A., Fiore M., Melchionda F., Indio V., Bertuccio S.N., Pession A. 2019. BCOR involvement in cancer. Epigenomics. 11, 835‒855.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoadley K.A., Yau C., Wolf D.M., Cherniack A.D., Tamborero D., Zou L., Ng S., Leiserson M. D. M., Niu B., McLellan M.D., Uzunangelov V., Zhang J., Kandoth C., Akbani R., Shen H., Omberg L., Chu A., Margolin A.A., Veer L. A. J., Lopez-Bigas N., Laird P.W., Raphael B.J., Ding L., Robertson A. G., Lauren A.B., Mills G.B., Weinstein J.N., Waes C.V., Chen Z., Collisson E.A., Cancer Genome Atlas Research Network, Benz C.C., Perou C.M., Stuart J.M. 2014. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 158, 929–944.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Böger C., Krüger S., Behrens H.M., Bock S., Haag J., Kalthoff H., Röcken C. 2017. Epstein–Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations. Ann. Oncol. 28, 1005–1014.

Article  PubMed  PubMed Central  Google Scholar 

Dong M., Wang H.Y., Zhao X.X., Chen J.N., Zhang Y.W., Huang Y., Xue L., Li H.G., Du H., Wu X.Y., Shao C.K. 2016. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein–Barr virus-associated gastric carcinoma. Hum. Pathol. 53, 25–34.

Article  CAS  PubMed  Google Scholar 

Derks S., Liao X., Chiaravalli A.M., Xu X., Camargo M.C., Solcia E., Sessa F., Fleitas T., Freeman G.J., Rodig S.J., Rabkin C.S., Bass A.J. 2016. Abundant PD-L1 expression in Epstein–Barr virus-infected gastric cancers. Oncotarget. 7, 32925–32932.

Article  PubMed  PubMed Central  Google Scholar 

Camargo M.C., Kim K.M., Matsuo K., Torres J., Liao L.M., Morgan D.R., Michel A., Waterboer T., Zabaleta J., Dominguez R.L., Yatabe Y., Kim S., Rocha-Guevara E.R., Lissowska J., Pawlita M., Rabkin C.S. 2016. Anti-Helicobacter pylori antibody profiles in Epstein–Barr virus (EBV)-positive and EBV-negative gastric cancer. Helicobacter. 21, 153–157.

Article  CAS  PubMed  Google Scholar 

Yanagi A., Nishikawa J., Shimokuri K., Shuto T., Taka-gi T., Takagi F., Kobayashi Y., Yamamoto M., Miura O., Yanai H., Suehiro Y., Yamasaki T., Yoshiyama H., Sakaida I. 2019. Clinicopathologic characteristics of Epstein–Barr virus-associated gastric cancer over the past decade in Japan. Microorganisms. 7, 305.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Beek J., zur Hausen A., Kranenbarg E.K., van de Velde C.J.H., Middeldorp J.M., van den Brule A.J.C., Meijer C.J.L.M., Bloemena E. 2004. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 22, 664–670.

Article  Google Scholar 

Sohn B.H., Hwang J.E., Jang H.J., Lee H.S., Oh S.C., Shim J.J., Lee K.W., Kim E.H., Yim S.Y., Lee S.H., Cheong J.H., Jeong W., Cho J.Y., Kim J., Chae J., Lee J., Kang W.K., Kim S., Noh S.H., Ajani J.A., Lee J.S. 2017. Clinical significance of four molecular subtypes of gastric cancer identified by The Cancer Genome Atlas Project. Clin. Cancer Res. 23, 4441–4449.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee H.S., Chang M.S., Yang H.K., Lee B.L., Kim W.H. 2004. Epstein–Barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein–Barr virus-negative carcinoma. Clin. Cancer Res. 10, 1698–1705.

Article  CAS  PubMed  Google Scholar 

Choi Y.Y., Bae J.M., An J.Y., Kwon I.G., Cho I., Shin H.B., Eiji T., Aburahmah M., Kim H.I., Cheong J.H., Hyung W.J., Noh S.H. 2014. Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. J. Surg. Oncol. 110, 129–135.

Article  PubMed  Google Scholar 

Smyth E.C., Wotherspoon A., Peckitt C., Gonzalez D., Hulkki-Wilson S., Eltahir Z., Fassan M., Rugge M., Valeri N., Okines A., Hewish M., Allum W., Stenning S., Nankivell M., Langley R., Cunningham D. 2017. Mismatch repair deficiency, microsatellite instability, and survival: an exploratory analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial. JAMA Oncol. 3, 1197–1203.

Article  PubMed  Google Scholar 

Choi Y.Y., Cheong J.H. 2019. Comment on ‘To Treat, or Not To Treat, That is the Question: biomarker-guided adjuvant chemotherapy for stage II and III gastric cancer’. Ann. Surg. 270, e40–e41.

Article  PubMed  Google Scholar 

Shin S.J., Kim S.Y., Choi Y.Y., Son T., Cheong J.-H., Hyung W.J., Noh S.H., Park C.-G., Kim H.-I. 2019. Mismatch repair status of gastric cancer and its association with the local and systemic immune response. Oncologist. 24, 835–844.

Article  Google Scholar 

Zhu L., Li Z., Wang Y., Zhang C., Liu Y., Qu X. 2015. Microsatellite instability and survival in gastric cancer: a systematic review and meta-analysis. Mol. Clin. Oncol. 3, 699–705.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Latham A., Srinivasan P., Kemel Y., Shia J., Bandlamudi C., Mandelker D., Middha S., Hechtman J., Zehir A., Dubard-Gault M., Tran C., Stewart C., Sheehan M., Penson A., DeLair D., Yaeger R., Vijai J., Mukherjee S., Galle J., Dickson M.A., Janjigian Y., O’Reilly E. M., Segal N., Saltz L.B., Reidy-Lagunes D., Varghese A.M., Bajorin D., Carlo M.I., Cadoo K., Walsh M.F., Weiser M., Aguilar J.G., Klimstra D.S., Diaz L.A., Baselga J., Zhang L., Ladanyi M., Hyman D.M., Solit D.B., Robson M.E., Taylor B.S., Offit K., Berger M.F., Stadler Z. K. 2019. Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer. J. Clin. Oncol. 37, 286–295.

Article  CAS  PubMed  Google Scholar 

Wu M.S., Sheu J.C., Shun C.T., Lee W.J., Wang J.T., Wang T.H., Cheng A.L., Lin J.T. 1997. Infrequent hMSH2 mutations in sporadic gastric adenocarcinoma with microsatellite instability. Cancer Lett. 112, 161–166.

Article  CAS  PubMed  Google Scholar